Drug Trial Radar · NCT02484092
A Gene Therapy Study for Hemophilia B
Last checked: Nov 20, 2026Latest source record: Jun 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Nov 18, 2015
Primary completion
Apr 8, 2019
Study completion Apr 8, 2019
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jun 29, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1/2, Open-Label, Non-Randomized, Dose-Escalation Study of SPK-9001 in Subjects with Hemophilia B.
Conditions
- Hemophilia B
Interventions
SPK-9001Biological
A novel, bioengineered adeno-associated viral vector carrying human factor IX variant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinically Significant Change From Baseline in Physical Examination FindingsTime frame: Baseline up to Week 52
- Number of Participants With Clinically Significant Change From Baseline in Vital SignsTime frame: Baseline up to Week 52
- Number of Participants With Clinical Laboratory Abnormalities Reported as TEAETime frame: Baseline up to Week 52
- Number of Participants With Drug -Related TEAEs and Serious Adverse Events (SAEs)Time frame: Baseline up to Week 52
- Number of Participants With Positive Immune Reponses Against Adeno-associated Virus Vector (AAV) CapsidTime frame: Baseline up to Week 52
- Number of Participants Who Reached > 150% Vector-derived FIX:C Activity Level After SPK-9001 InfusionTime frame: Baseline up to Week 52
- Number of Participants With FIX InhibitorTime frame: Baseline up to Week 52
- Incremental Recovery of FIX ProductTime frame: Day 0 and Week 52
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
UC Davis Comprehensive Cancer Center
Sacramento, California
UC Davis CTSC Clinical Research Center
Sacramento, California
UC Davis Ellison Ambulatory Care Clinic
Sacramento, California
UC Davis Investigational Pharmacy
Sacramento, California
UC Davis Medical Center
Sacramento, California
University of Mississippi Medical Center
Jackson, Mississippi
Mississippi Center for Advanced Medicine
Madison, Mississippi
Weill Cornell Medicine - New York Presbyterian Hospital
New York, New York
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Royal Prince Alfred Hospital
Camperdown/Sydney, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.